The immunoassay market is entering a period of steady expansion as healthcare systems increasingly prioritize early disease detection, biomarker analysis, personalized medicine, and rapid diagnostic testing. The market was valued at USD 28.0 billion in 2025 and is estimated to reach USD 29.3 billion in 2026, before growing to USD 40.3 billion by 2033. It is projected to expand at a 4.6% CAGR...
The growing demand for rapid diagnostic testing, increasing prevalence of chronic and infectious diseases, and continuous advancements in point-of-care technologies are driving the growth of the global Microfluidic Immunoassay Market. Microfluidic immunoassays are advanced diagnostic technologies that combine microfluidic systems with immunological testing methods to detect specific biomarkers,...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek